Department of Health
and Human Services (HHS)
and Human Services (HHS)
October 19, 2020
PAR-20-214 - Research to Improve Native American Health (R21 Clinical Trials Optional)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)
The purpose of this notice is to inform potential applicants that the Office of Disease Prevention (ODP) will participate, effective immediately, in PAR-20-214: “Research to Improve Native American Health (R21 Clinical Trials Optional).”
The following text has been added to reflect ODP’s participation in this FOA.
Part 1. Overview Information
Components of Participating Organizations
Office of Disease Prevention (ODP)
Part 2. Full Text of Announcement
Section I. Funding Opportunity Description
Specific Research Objectives and Scope
Office of Disease Prevention (ODP)
The Office of Disease Prevention is interested in co-funding applications that focus on developing and testing health promotion and disease prevention interventions to improve health in Native American (NA) populations and research on dissemination and implementation strategies to address barriers to adoption, integration, scale-up, and sustainability of effective interventions. These interventions should have strong implications for disease prevention and make use of innovative design, measurement, and analytic methods relevant to the overall objectives of this funding opportunity announcement. Applications must also be relevant to the objectives of at least one of the participating NIH Institutes and Centers (IC) listed in PAR-20-214. ODP does not award grants. Please contact the relevant IC program contact listed for questions related to IC research priorities and funding.
Design, Analysis, and Sample Size Considerations for Studies to Evaluate Interventions:
Investigators seeking to evaluate the effect of an intervention on a health-related biomedical or behavioral outcome may propose a study design in which (1) groups or clusters are assigned to study arms and individual observations are analyzed to evaluate the effect of the intervention, or (2) participants are assigned individually to study arms but receive at least some of their intervention in a group format or through a shared facilitator. Designs that might be proposed include parallel group- or cluster-randomized trials, stepped-wedge group- or cluster-randomized trials, individually randomized group-treatment trials, multiple baseline designs, time-series designs, and other quasi-experimental designs. Whenever participants are assigned in groups or clusters (e.g., families, clinics, schools, worksites, communities), or participants receive some part of their intervention in a group format or through a shared facilitator, and observations on individual participants are analyzed for between-group effects, special methods are required for analysis and sample size. Applicants will need to show that their methods are appropriate given their plans for assignment of participants and delivery of interventions. Additional information is available at https://researchmethodsresources.nih.gov/.
Section VII. Agency Contacts
Scientific/Research Contact(s)
Melissa C. Green Parker, PhD
Office of Disease Prevention (ODP)
Telephone: 301-480-1161
Email: [email protected]
All other aspects of PAR-20-214 remain unchanged.
Melissa C. Green Parker, PhD
Office of Disease Prevention (ODP)
Telephone: 301-480-1161
Email: [email protected]